InvestorsHub Logo
Followers 45
Posts 1512
Boards Moderated 0
Alias Born 11/25/2013

Re: iryokabu post# 339932

Sunday, 05/16/2021 10:48:32 PM

Sunday, May 16, 2021 10:48:32 PM

Post# of 423948
Iryokabu
RESPECT-EPA:

Objectives
Narrative objectives1 Patients with chronic coronary artery disease receiving LDL-C lowering treatment by statin will be randomized to either a control group (standard treatment) or EPA group (standard treatment plus eicosapentaenoic acid), to examine the effects of eicosapentaenoic acid on the incidence of cardiovascular events. *****Relationship between EPA/AA ratio and incidence of event will be also examined.***** - I love this part!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News